Sotera Health Company (SHC) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
Sotera Health Company (SHC) carries a Roarable Rating of C (Hold) with 63/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
How SHC Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $1.16B | 55.5% | 7.9% | $77.9M | $149.2M | 3% |
| FY 2024 | $1.10B | 54.7% | 27% | $44.4M | $45.1M | 10.1% |
| FY 2023 | $1.05B | 44% | 26.4% | $51.4M | -$194.9M | 12.3% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring SHC)
- ✓Live walkthrough of SHC's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
SHC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +5.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on SHC today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for SHC. Explore sector supply chains on /butterfly.
SHC Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is Sotera Health Company (SHC)?
In FY 2025 (10-K), SHC converted $1.2B of revenue into a 55.5% gross margin, 7.9% operating margin, and $149.2M in free cash flow (12.8% FCF margin).